Register | Login or

General Information

Websitehcven.com
Phone617.252.4343
Email
Employees
DescriptionVenture capital Firm

Funds

Offices

Cambridge, USA
55 Cambridge Parkway
Suite 301
Cambridge, MA, 02142-1234
USA
Princeton, USA
44 Nassau Street
Princeton, NJ, 08542-4511
USA

People

Managing Director and Co-founder
Managing Director
Managing Partner

Tags

HealthCare Ventures

HealthCare Ventures is a leading venture capital firm specializing in life science industry investing. At HealthCare Ventures we concentrate our investment dollars on life science companies showing high growth potential. Since 1985, we have maintained a constant objective to support entrepreneurs and to generate above average returns for our limited partners.

Milestones

Investments

Company Date Round Size Participants
Radius Health 2/12Series C$21.4M7
Mosaic Biosciences 11/11Series A$1M3
Sensors for Medicine and Science 11/11Series D$54.1M5
Pathogenetix 11/11Series B$7.5M4
Tensha Therapeutics 9/11Series A$15M1
Cleveland HeartLab 8/11Series B$18.4M2
Pathogenetix 8/11Series B$4M3
Radius Health 7/11Series C$66M7
nanoMR 7/11Series B$13M4
CellNovo 2/11Series B£30M8
Dicerna Pharmaceuticals 10/10Series B$4M2
DecImmune Therapeutics 9/10Unattributed$3.2M3
Anchor Therapeutics 8/10Series B$10M3
TetraLogic Pharmaceuticals 8/10Series C$32M8
Stemgent 7/10Series B$5.6M2
Trevena 7/10Series B$35M4
Foldrx Pharmaceuticals 6/10Unattributed$29M7
Theraclone Sciences 3/10Unattributed$1.5M6
Seahorse Bioscience 3/10Series D$5M7
Stemgent 11/09Debt$2.7M2
PharmAthene 7/09Unattributed$19.3M4
Xanodyne 6/09Series D$38M7
VaxInnate 6/09Series D$30M7
Seahorse Bioscience 3/09Series D$6M7
Catalyst Biosciences 12/08Series C$40M7
Radius Health 11/08Series C$15M6
Proteostasis Therapeutics 8/08Series A$45M5
Trevena 3/08Series A$24M4
Ascent Therapeutics 11/07Series A$8M3
Radius Health 4/07Series B$57.5M6
Sequoia Pharmaceuticals 1/07Series C$35M5
VaxInnate 10/06Series C$40M6
Promedior 5/06Series A$14M5
Avidia 5/06Series C$43.8M7
Catalyst Biosciences 2/06Series B$30M6
Sequoia Pharmaceuticals 3/05Series B$22M4

Videos

Sources

  1. Radius Health, Inc.: Series C $21.4M (onbiovc.com) [edit]
  2. Mosaic Biosciences, Inc.: Series A $1M (onbiovc.com) [edit]
  3. Sensors for Medicine and Science Raises $54.1 Million Series D Financing (pr-inside.com) [edit]
  4. PathoGenetix adds $7.5M to Series B funding (masshightech.com) [edit]
  5. Tensha Therapeutics Raises $15M in Series A Financing (finsmes.com) [edit]
  6. Cleveland HeartLab Completes $18.4M Series B Financing Round (finsmes.com) [edit]
  7. PathoGenetiX Inc. completes first close of Series B Financing ... (pathogenetix.com) [edit]
  8. Radius Health, Inc.: Series C $66M (onbiovc.com) [edit]
  9. nanoMR Announces $13 Million Series B Financing (ca.finance.yahoo.com) [edit]
  10. CELLNOVO SECURES £30 MILLION IN SERIES B FINANCING (cellnovo.com) [edit]
  11. Dicerna makes $29M second close on Series B funding round (masshightech.com) [edit]
  12. DecImmune Therapeutics Receives $1M in Equity Financing; $2.2M Phase II SBIR Funding (finsmes.com) [edit]
  13. Anchor Therapeutics Secures $10 Million Series B Financing to Advance Pepducin Drug Candidates (anchortx.com) [edit]
  14. TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy (fiercebiotech.com) [edit]
  15. Stemgent, Inc.: Series B $5.6M (onbiovc.com) [edit]
  16. Trevena, Inc.: Series B $35M (onbiovc.com) [edit]
  17. FoldRx banks $29M for neurodegenerative drug application (fiercebiotech.com) [edit]
  18. Theraclone Raises $1.5M (xconomy.com) [edit]
  19. Seahorse Bioscience, Inc.: Series D $5M (onbiovc.com) [edit]
  20. Stemgent issues notes to raise $2.7M (masshightech.com) [edit]
  21. PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants (ir.pharmathene.com) [edit]
  22. Xanodyne Pharmaceuticals, Inc.: Series D $38M (onbiovc.com) [edit]
  23. VaxInnate Corp., Series D $30M (onbiovc.com) [edit]
  24. Seahorse Bioscience lands $6M, buys BioProcessors Corp (masshightech.com) [edit]
  25. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
  26. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million (radiuspharm.mwnewsroom.com) [edit]
  27. Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs (reuters.com) [edit]
  28. Trevena, Inc. Announces $24 Million Series A Financing (trevenainc.com) [edit]
  29. Ascent Therapeutics Secures $8 Million Series A (venturedeal.com) [edit]
  30. Radius Raises $57.5 Million in Second Private Financing Round (radiuspharm.com) [edit]
  31. Sequoia Pharmaceuticals Raises $35M In Series C Financing (fiercebiotech.com) [edit]
  32. VaxInnate Secures $40 Million Series C Financing. (thefreelibrary.com) [edit]
  33. Cap Funding Report [edit]
  34. AVIDIA RAISES $43.8 MILLION TO ADVANCE NEW CLASS OF PHARMACEUTICALS (freshnews.com) [edit]
  35. CATALYST BIOSCIENCES RAISES $30 MILLION SERIES B FINANCING TO ADVANCE THERAPEUTIC PROTEASES (catalystbiosciences.com) [edit]
  36. Sequoia Pharmaceuticals Secures Funding to Test its Unique AIDS Drug (articleyoube.com) [edit]
Edit This Page
Last Edited 2/13/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy